Global Pharmaceuticals & Biotech Top Stock Picks from Analysts

Cryoport

Market Cap: US$358.5m

Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.

BINEX

Market Cap: ₩504.5b

Operates as a pharmaceutical company in South Korea.

Inventiva

Market Cap: €309.9m

A clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of MASH and other diseases in France, the United States, and Internationally.

SNDL

Market Cap: US$339.6m

Engages in the production, distribution, and sale of cannabis products in Canada.

Benitec Biopharma

Market Cap: US$335.0m

A clinical-stage biotechnology company, focuses on the development of novel genetic medicines.

ImmuneOnco Biopharmaceuticals (Shanghai)

Market Cap: HK$2.6b

A biotechnology company, engages in the research and development of immuno-oncology therapies in the People’s Republic of China.

Pacific Biosciences of California

Market Cap: US$330.1m

Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.

Rigel Pharmaceuticals

Market Cap: US$326.9m

A biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer.

Foresee Pharmaceuticals

Market Cap: NT$9.9b

Operates as biopharmaceutical company in the United States, China, and Europe.

Olema Pharmaceuticals

Market Cap: US$325.4m

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers.

Capricor Therapeutics

Market Cap: US$324.8m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Essex Bio-Technology

Market Cap: HK$2.5b

An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.

Beximco Pharmaceuticals

Market Cap: ৳38.6b

Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.

Emergent BioSolutions

Market Cap: US$317.3m

A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.

Cresco Labs

Market Cap: CA$439.8m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

Arcturus Therapeutics Holdings

Market Cap: US$314.3m

Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

Heron Therapeutics

Market Cap: US$312.8m

A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.

Septerna

Market Cap: US$310.7m

A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.

Dong-A ST

Market Cap: ₩436.9b

Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.

Entrada Therapeutics

Market Cap: US$306.7m

A clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.

XOMA Royalty

Market Cap: US$296.3m

Operates as a biotech royalty aggregator in the United States and the Asia Pacific.

Senores Pharmaceuticals

Market Cap: ₹25.1b

Develops, manufactures, and sells, pharmaceutical products in India, the United States, Canada, and internationally.

aTyr Pharma

Market Cap: US$287.9m

A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.

Atai Life Sciences

Market Cap: US$287.7m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.

Alumis

Market Cap: US$285.6m

A clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders.

Aquestive Therapeutics

Market Cap: US$283.1m

Operates as a pharmaceutical company in the United States and internationally.

Compass Therapeutics

Market Cap: US$277.9m

A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.

Quantum-Si

Market Cap: US$276.5m

A life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).

Corvus Pharmaceuticals

Market Cap: US$276.3m

A clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.

Immutep

Market Cap: AU$423.5m

A late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia.

Abeona Therapeutics

Market Cap: US$271.8m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Cartesian Therapeutics

Market Cap: US$271.0m

A clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases.

Jade Biosciences

Market Cap: US$269.6m

Operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases.

Aura Biosciences

Market Cap: US$268.9m

A clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors.

iTeos Therapeutics

Market Cap: US$264.9m

A clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer.

Terns Pharmaceuticals

Market Cap: US$263.8m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.